Dr. Jain is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
4915 E Baseline Rd
Suite 112
Gilbert, AZ 85234Phone+1 480-626-6600Fax+1 480-626-6604
Education & Training
- University of Colorado School of Medicine/National Jewish Health (Adult)Fellowship, Allergy and Immunology, 2002 - 2004
- Phoenix Children's HospitalResidency, Pediatrics, 1999 - 2002
- Medical College of WisconsinClass of 1999
- Arizona State UniversityB.S., Biology, Magna Cum Laude, 1991 - 1994
Certifications & Licensure
- AZ State Medical License 2009 - 2025
- WI State Medical License 2004 - 2019
- CO State Medical License 2003 - 2017
- American Board of Allergy and Immunology Allergy & Immunology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification SuiteMed EMR, Fox Meadows Software, 2012-2013
- Chief Resident PCH/MMC Pediatric Residency Program, 2001-2002
- Senior Resident of the Year PCH/MMC Pediatric Residency Program, 2001-2002
- Join now to see all
Clinical Trials
- A Study of CDX-0159 in Patients With Chronic Spontaneous Urticaria Start of enrollment: 2020 Sep 24
Roles: Contact, Principal Investigator
Publications & Presentations
PubMed
- 2 citationsDupilumab-Treated Patients with Asthma in the Real World: The RAPID Global Registry.Rebecca Gall, Neal Jain, Weily Soong, Russell A Settipane, Changming Xia
Advances in Therapy. 2023-03-01 - 4 citationsBaseline Demographics and Severity and Burden of Atopic Dermatitis in Adult Patients Initiating Dupilumab Treatment in a Real-World Registry (PROSE).Jerry Bagel, Tien Q Nguyen, Hermenio Lima, Neal Jain, David M Pariser
Dermatology and Therapy. 2022-06-01 - 2 citationsThe National Heart Lung and Blood Institute guidelines finally say "yes" to fractional exhaled nitric oxide.Neal Jain, Jennifer Leigh Hill
Annals of Allergy, Asthma & Immunology. 2022-04-01
Journal Articles
- Correspondence: Should exhaled nitric oxide be part of routine asthma management.Jain N, Boggs P, Zitt M, Ann Allergy Asthma Immunol, 1/1/2013
- A novel mutation in NFKBIA/IKBA results in a degradation-resistant N-truncated protein and is associated with ectodermal dysplasia with immunodeficiency.Lopez-Granados E, Keenan JE, Kinney MC, Leo H, Jain N, Ma CA, Quinones R, Gelfand EW, Jain A, Human Mutation, 1/1/2008
- Effect of Montelukast on Peripheral Airflow Obstruction in Children with Asthma.Spahn JD, Covar RA, Jain N, Gleason M, Szefler SJ, Gelfand EW, Annals of Allergy, Asthma and Immunology, 1/1/2006
- Join now to see all
Abstracts/Posters
- Meta Analysis of Asthma Exacerbation Rates During Asthma Managed Using Fractional Exhaled Nitric Oxide Versus Standard Clinical Parameters Alone.Jain N, Dorinsky P, Donahue J, American College of Allergy Asthma and Immunology 2012 Annual Conference, Orlando, Florida., 1/1/2012
- Quantitative High Resolution CT Demonstrates Evidence for Peripheral Airway Disease in Asthmatic Children with Normal FEV1.Jain N, Gleason M, Covar R, Newell JD, Gelfand EW, Spahn JD, AAAAI 2004 national meeting in San Francisco, CA., 1/1/2004
- Foramen of Morgagni Hernia as the Cause of Recurrent Respiratory Complaints in a 17 year-old Previously Diagnosed with Severe Asthma.Jain N, Boguniewicz M, Larsen GL, Hay TC, ACAAI 2003 meeting, New Orleans, LA., 1/1/2003
- Join now to see all
Lectures
- Lemierre’s Disease Presenting as Septic Arthritis.“Academic Excellence Day”, Maricopa medical Center, Phoenix, AZ - 1/1/1999
Other
- AAAAI/ACAAI Joint Statement of Support of the ATS Clinical Practice Guideline: Interpretation of Exhaled Nitric Oxide for Clinical Applications.Zitt M, Oppehneimer J, Bernstein D, Boggs P, Dinakar C, Jain N, Katial R, Sands M, Szefler S
http://www.acaai.org/Documents/FeNOJointStatement3-6-12.pdf.
4/23/2012
Press Mentions
- ATS 2021 Breaking News Session to Feature Pivotal Data on REGEN-COV™ (Casirivimab with Imdevimab) and Dupixent® (Dupilumab)May 3rd, 2021
- Managing Asthma with Biologic TherapyMay 1st, 2019
- Biologics in Asthma: Treatment SelectionApril 29th, 2019
- Join now to see all
Professional Memberships
- Fellow
- Member
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: